Search research articles
Contact Us
Filters
Showing results (221-230 of 293) with videos related to
Page
of 30
Sort By:
BMC Musculoskeletal Disorders
|
January 14, 2014
Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study
Hubert G Nüßlein, Rieke Alten, Mauro Galeazzi, et al.
Journal of Clinical Medicine
|
December 23, 2022
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)
Michaela Koehm, Ann C Foldenauer, Tanja Rossmanith, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 6, 2005
Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease
Nicolas W J Schröder, Isabel Diterich, Antje Zinke, et al.
Arthritis Research & Therapy
|
March 24, 2018
Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis
Florian Weigold, Jeannine Günther, Moritz Pfeiffenberger, et al.
Drug Safety
|
February 2, 2020
An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data
Gerd R Burmester, Jeffrey R Curtis, Huifeng Yun, et al.
Rheumatology and Therapy
|
January 5, 2024
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years
Christina Charles-Schoeman, Jon T Giles, Nancy E Lane, et al.
Rheumatology (Oxford, England)
|
March 19, 2021
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
Frank Behrens, Michaela Koehm, Tanja Rossmanith, et al.
Annals of the Rheumatic Diseases
|
June 29, 2012
Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study
Jacqueline Detert, Hans Bastian, Joachim Listing, et al.
RMD Open
|
October 10, 2022
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination
Elisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, et al.
Expert Opinion on Biological Therapy
|
June 21, 2024
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study
Kyung-Sang Yu, Hyunwook Ryu, Dongseong Shin, et al.
Page
of 30
Search research articles
Search
Showing results (221-230 of 293) with videos related to
Sort By:
Page
of 30
BMC Musculoskeletal Disorders
|
January 14, 2014
Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study
Hubert G Nüßlein, Rieke Alten, Mauro Galeazzi, et al.
Journal of Clinical Medicine
|
December 23, 2022
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)
Michaela Koehm, Ann C Foldenauer, Tanja Rossmanith, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 6, 2005
Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease
Nicolas W J Schröder, Isabel Diterich, Antje Zinke, et al.
Arthritis Research & Therapy
|
March 24, 2018
Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis
Florian Weigold, Jeannine Günther, Moritz Pfeiffenberger, et al.
Drug Safety
|
February 2, 2020
An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data
Gerd R Burmester, Jeffrey R Curtis, Huifeng Yun, et al.
Rheumatology and Therapy
|
January 5, 2024
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years
Christina Charles-Schoeman, Jon T Giles, Nancy E Lane, et al.
Rheumatology (Oxford, England)
|
March 19, 2021
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
Frank Behrens, Michaela Koehm, Tanja Rossmanith, et al.
Annals of the Rheumatic Diseases
|
June 29, 2012
Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study
Jacqueline Detert, Hans Bastian, Joachim Listing, et al.
RMD Open
|
October 10, 2022
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination
Elisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, et al.
Expert Opinion on Biological Therapy
|
June 21, 2024
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study
Kyung-Sang Yu, Hyunwook Ryu, Dongseong Shin, et al.
Page
of 30